Medline Inc. (MDLN)
Medline will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

Company Description

Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care, based on total net sales of med-surg products.

We deliver mission-critical products used daily across the full range of care settings, from hospitals and surgery centers to physician offices and post-acute facilities.

Through our two segments, Medline Brand and Supply Chain Solutions, we offer approximately 335,000 med-surg products, including surgical and procedural kits, gloves and protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products.

We hold the leading position across several of our end markets and many of our key product families. We distribute these products through our expansive network of 69 global distribution facilities, spanning over 29 million square feet of warehouse space, and our owned fleet of over 2,000 MedTrans trucks, enabling us to provide next-day delivery to 95% of our U.S. customers.

Medline Inc.
Country United States
Founded 1966
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 43,000
CEO James Boyle

Contact Details

Address:
3 Lakes Drive
Northfield, IL 60093
United States
Phone (847) 949-5500
Website medline.com

Stock Details

Ticker Symbol MDLN
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0002046386
Employer ID 33-1845288
SIC Code 3841

Key Executives

Name Position
James M. Boyle Chief Executive Officer and Director
James M. Pigott President
Michael B. Drazin Chief Financial Officer
Stephen L. Miller Chief Operating Officer
Alex M. Liberman Chief Legal Officer
Douglas P. Golwas Chief Commercial Officer
Christopher P. Shryock Chief Human Resources Officer
Amanda H. Laabs Chief Product Officer
William J. Abrams Executive Vice President, Supply Chain Solutions
Charles N. Mills Chair of the Board of Directors

Latest SEC Filings

Date Type Title
Nov 4, 2025 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Oct 28, 2025 S-1 General form for registration of securities under the Securities Act of 1933
Aug 15, 2025 DRS/A [Amend] [Cover] Draft Registration Statement
Mar 19, 2025 DRS/A [Amend] [Cover] Draft Registration Statement
Feb 28, 2025 DRS/A [Amend] [Cover] Draft Registration Statement
Jan 31, 2025 DRS/A [Amend] [Cover] Draft Registration Statement
Dec 19, 2024 DRS [Cover] Draft Registration Statement